primer pair for qnrS was 5Ј-GCAAGTTCATTGAACAGGG T-3Ј and 5Ј-TCTAAACCGTCGAGTTCGGC-3Ј (yielding a 428-bp product). The gene gyrA was amplified with primers 5Ј-TTAATGATTGCCGCCGTCGG-3Ј and 5Ј-TACACCGG TCAACATTGAGG-3Ј (yielding a 648-bp product) and parC was amplified with primers 5Ј-AAACCTGTTCAGCGCCGC ATT-3Ј and 5Ј-GTGGTGCCGTTAAGCAAA-3Ј (yielding a 395-bp product) to evaluate possible coexisting chromosomal mutations. The corresponding specific PCR products were sequenced by LARK Technologies, Essex, United Kingdom.
For the qnr-positive isolates, synergy experiments were also performed using ciprofloxacin and the efflux pump inhibitor CCCP (carbonyl cyanide m-chlorophenylhydrazone) (8) to check the contribution of efflux pump overexpression to ciprofloxacin resistance. Pulsed-field gel electrophoresis (PFGE) analysis of XbaI-digested genomic DNA was performed, and the banding patterns of the strains were compared visually according to the criteria proposed by Tenover et al. (9) . Filter mating experiments were performed with qnr-positive isolates by using E. coli 26R793 (lac negative and rifampin resistant) as the recipient. Transconjugants were selected on MacConkey agar plates containing 100 mg of rifampin/liter and 6 mg of nalidixic acid/liter, tested for qnr genes by PCR, and analyzed for plasmids by alkaline lysis.
Eleven of the 113 E. coli isolates (10%) derived from three independent hospitals in Thessaly (Larissa, central Greece) and Macedonia (Thessaloniki, northern Greece) and exhibiting nine unrelated PFGE strain patterns were qnr positive. The ciprofloxacin MICs for these isolates were 16 to 128 g/ml; the characteristics of the isolates are presented in Table 1 . One Qnr-positive isolate (isolate 3) was an extended-spectrum ␤-lactamase producer carrying the gene bla . No synergy between CCCP and ciprofloxacin in any isolate was observed. Sequencing of the PCR products showed that all 11 isolates carried the allele qnrS1, that none carried qnrA or qnrB, and that all had the mutations in the genes gyrA and parC that commonly confer ciprofloxacin resistance on E. coli isolates (2, 4) ( Table 1) . Mating experiments revealed that qnrS1 gene-carrying plasmids of various molecular sizes in 5 of the 11 isolates were transferable to the susceptible host. Ciprofloxacin MICs for the transconjugants were 0.25 to 0.5 g/ml, while the MIC for the susceptible E. coli recipient was 0.032 g/ml.
The presence of the qnr genes in clinical isolates from Greece had not been reported previously. In this study, a considerably high proportion, 10%, of quinolone-resistant E. coli isolates were found to carry the gene qnrS1. The predominance in Greece of the qnr variant qnrS1, which was up to now detected mainly among salmonellae (4) and more rarely in E. coli (7) in Europe, indicates its possibly wide distribution. The carriage of qnrS1 in unrelated isolates of E. coli indicates either the natural existence of this gene in microbial populations or its wide horizontal spread through plasmids or integrons.
In conclusion, qnr genes seem to be common in ciprofloxacin-resistant clinical E. coli isolates and may contribute to the alarming rates of quinolone resistance in Greece.
